Cop 1 for treatment of inflammatory bowel diseases

Details Cop 1 for treatment of inflammatory bowel diseases Cop 1 for treatment of inflammatory bowel diseases

A - Human Necessities

61

K

A61K 38/02 (2006.01) A61K 31/785 (2006.01) A61P 29/00 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2513567

The present invention relates to the use of Copolymer 1 (glatiramer acetate), a Copolymer 1-related polypeptide, or a Copolymer 1-related peptide, for the treatment of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

La présente invention concerne l'utilisation du copolymère 1 (acétate de Glatiramer), d'un polypeptide associé au copolymère 1 ou d'un peptide associé au copolymère 1, dans le traitement de maladies entériques inflammatoires, telles que la maladie de Crohn et la colite ulcéreuse.

Affiliated with

Also associated with

Rating

Cop 1 for treatment of inflammatory bowel diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cop 1 for treatment of inflammatory bowel diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cop 1 for treatment of inflammatory bowel diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1841567